Tag: Health Claims

Displaying 21 - 40 of 606 results.

Pages

“Just like the white winged dove sings a song,” you can count on the BCP Business Blog to celebrate the “Edge of Seventeen” – 2017, of course – with a recap of in-case-you-missed-it developments from 2016. (Sorry, Stevie Nicks. That was a stretch.) In no particular order, here is our...
Following a public comment period, the Federal Trade Commission has approved a final consent order with Mars Petcare U.S. settling charges that the company falsely advertised specific health benefits of its Eukanuba brand dog food.
The Federal Trade Commission has granted summary decision against California Naturel, Inc., for falsely advertising its sunscreen product as “all natural” in violation of Sections 5 and 12 of the FTC Act.
Is it time for a little heart-to-heart about making health claims for mobile apps? An FTC settlement with California-based Aura Labs challenges misleading representations the company made about its Instant Blood Pressure app. In addition, if you keep your finger on the pulse of FTC...
The marketers of a mobile app designed to measure blood pressure have agreed to settle Federal Trade Commission charges that they deceived consumers with claims that their Instant Blood Pressure (IBP) app was as accurate as a traditional blood pressure cuff. In addition, the Commission alleged that...
The FTC applies a consistent approach to evaluating ad claims. Companies must have a reasonable basis for objective representations, including claims that a product can treat specific health conditions. Whether it’s an over-the-counter drug, dietary supplement, or food, the same...
Federal Register Notice: Federal Trade Commission Enforcement Policy Statement on Marketing Claims for Over-the-Counter Homeopathic Drugs
The Federal Trade Commission today announced a new “Enforcement Policy Statement on Marketing Claims for Over-the-Counter (OTC) Homeopathic Drugs.” The policy statement was informed by an FTC workshop held last year to examine how such drugs are marketed to consumers.
In an eye exam, the bottom line is the toughest to see. But responsible eye care prescribers and contact lens sellers clearly understand another “bottom line”: They comply with the FTC’s Contact Lens Rule.
At the request of the Federal Trade Commission, a U.S. district court judge issued a summary decision and $30 million judgment against the pitchman behind a product called Pure Green Coffee, who deceived consumers using false weight-loss claims, bogus testimonials, and fake news websites.
The defendants behind a group of California-based marketers have been permanently barred from the deceptive marketing and billing tactics they allegedly used to promote their skincare products, under court orders resolving Federal Trade Commission charges against them. Twenty-nine defendants who...
The sellers of Supple, a glucosamine and chondroitin liquid supplement, have agreed to settle Federal Trade Commission charges that they falsely advertised that their product provided complete relief from chronic and severe joint pain caused by arthritis and fibromyalgia and was scientifically...
As consumers age, they want to remain supple, as in limber, lithe, and flexible. Ads for the beverage Supple claimed the product would provide complete and long-lasting relief from joint pain and treat chronic pain caused by arthritis and fibromyalgia. But according to the FTC, the...
In a victory for consumers, the U.S. Court of Appeals for the Second Circuit has upheld a lower court ruling requiring the operator of an affiliate marketing group to pay $11.9 million for its part in helping to promote LeanSpa, a deceptively marketed weight-loss supplement.
A U.S. district court judge has ruled that COORGA Nutraceuticals Corporation and its principal Garfield Coore violated the law by claiming their “Grey Defence” dietary supplements reversed or prevented gray hair. The Federal Trade Commission filed a complaint challenging the claims as unfounded in...

Pages